Subject: | |
From: | |
Reply To: | |
Date: | Mon, 29 Aug 2005 18:32:18 EDT |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
<<Disclaimer: Verify this information before applying it to your situation.>>
SEARCH
Medscape
MEDLINE
DrugInfo
Medscape Features
Meeting Unmet Needs in Acid-Related Diseases:
New implications for treating acid-related disorders.
Demystifying Biologic Therapies for Crohn's Disease CME:
As biologic therapies become more widely used to treat CD, it is important
that product characteristics, MOA, pharmacokinetics, and monitoring parameters
be understood fully.
Crohn's Disease: Blocking The Inflammatory Cycle
Review IBD therapies, from biologics, to selective adhesion molecules and
alpha-4 inhibition.
Patient Education
Find Resources For Your Patients
Member Benefits
Try a 30-day No Risk trial of ACP Medicine, the reference of the American
College of Physicians.
Evidence-based, peer-reviewed recommendations on current best practices.
Learn More.
Contact Us
Editorial Comments
Maria L. Gaiso, PhD
[log in to unmask]
Technical Support
[log in to unmask]
Mailing Address
WebMD Medscape
Attn: email newsletters
224 W. 30th Street
New York, NY 10001
From : [log in to unmask]
Top Stories
Is Coeliac Disease Screening in Risk Groups Justified? A Fourteen-Year
Follow-up With Special Focus on Compliance and Quality of Life
This is the direct link to the article.
http://www.medscape.com/viewarticle/510580_1
You may have to register if you haven't done so already.
Bev in Milwaukee
*Support summarization of posts, reply to the SENDER not the Celiac List*
|
|
|